{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:14:52Z","timestamp":1792815292602,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.111931","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T22:17:12Z","timestamp":1711577832000},"page":"111931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3\/STAT3 pathway"],"prefix":"10.1016","volume":"132","author":[{"given":"Wenyang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5887-7192","authenticated-orcid":false,"given":"Dan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111931_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1289194","article-title":"Acute lung injury caused by sepsis: how does it happen?","volume":"10","author":"Sun","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2024.111931_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/CS20211156","article-title":"Buformin alleviates sepsis-induced acute lung injury via inhibiting NLRP3-mediated pyroptosis through an AMPK-dependent pathway","volume":"136","author":"Liu","year":"2022","journal-title":"Clinical Sci. (London England. 1979)"},{"key":"10.1016\/j.intimp.2024.111931_b0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/CS20210879","article-title":"Pathogenesis of pneumonia and acute lung injury","volume":"136","author":"Long","year":"2022","journal-title":"Clinical Sci. (London England. 1979)"},{"key":"10.1016\/j.intimp.2024.111931_b0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13105-022-00909-1","article-title":"Pyroptosis in inflammation-related respiratory disease","volume":"78","author":"Feng","year":"2022","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2024.111931_b0025","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.111931_b0030","article-title":"Metformin alleviates LPS-induced acute lung injury by regulating the SIRT1\/NF-\u03baB\/NLRP3 pathway and inhibiting endothelial cell pyroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111931_b0035","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.7150\/thno.43108","article-title":"A COX-2\/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2024.111931_b0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12964-019-0366-y","article-title":"Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-\u03baB pathways","volume":"17","author":"Yang","year":"2019","journal-title":"Cell Communication and Signaling : CCS"},{"key":"10.1016\/j.intimp.2024.111931_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"10.1016\/j.intimp.2024.111931_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2020.100016","article-title":"Glycolysis and gluconeogenesis: a teaching view","volume":"296","author":"Hern\u00e1ndez","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.111931_b0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41423-022-00962-2","article-title":"Pnpt1 mediates NLRP3 inflammasome activation by MAVS and metabolic reprogramming in macrophages","volume":"20","author":"Hsu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.111931_b0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","article-title":"An update on the regulatory mechanisms of NLRP3 inflammasome activation","volume":"18","author":"Paik","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.111931_b0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7150\/ijbs.77304","article-title":"TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury","volume":"19","author":"Zhong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2024.111931_b0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17512433.2019.1615443","article-title":"JAK3-selective inhibitor peficitinib for the treatment of rheumatoid arthritis","volume":"12","author":"Qiu","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111931_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110753","article-title":"Peficitinib ameliorates 5-fluorouracil-induced intestinal damage by inhibiting aging, inflammatory factors and oxidative stress","volume":"123","author":"He","year":"2023","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.intimp.2024.111931_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300083","article-title":"Pretreatment with kahweol attenuates sepsis-induced acute lung injury via improving mitochondrial homeostasis in a CaMKKII\/AMPK-dependent pathway","volume":"67","author":"Li","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.intimp.2024.111931_b0085","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s00018-022-04628-0","article-title":"A novel mechanism for the protection against acute lung injury by melatonin: mitochondrial quality control of lung epithelial cells is preserved through SIRT3-dependent deacetylation of SOD2","volume":"79","author":"Ning","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2024.111931_b0090","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s40265-019-01131-y","article-title":"Peficitinib: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2024.111931_b0095","doi-asserted-by":"crossref","unstructured":"T. Takeuchi, Y. Tanaka, S. Tanaka, A. Kawakami, Y.W. Song, Y.H. Chen, M. Rokuda, H. Izutsu, S. Ushijima, Y. Kaneko, Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan, Rheumatology and therapy, 8 (2021) 425-442.","DOI":"10.1007\/s40744-021-00280-5"},{"key":"10.1016\/j.intimp.2024.111931_b0100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/1060028013512790","article-title":"Tofacitinib: the first janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis","volume":"47","author":"Vyas","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2024.111931_b0105","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/cr.2015.63","article-title":"Park7 interacts with p47(phox) to direct NADPH oxidase-dependent ROS production and protect against sepsis","volume":"25","author":"Liu","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.intimp.2024.111931_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105741","article-title":"MCP-induced protein 1 attenuates sepsis-induced acute lung injury by modulating macrophage polarization via the JNK\/c-Myc pathway","volume":"75","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacology"},{"key":"10.1016\/j.intimp.2024.111931_b0115","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.4049\/jimmunol.1102969","article-title":"The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsis","volume":"189","author":"Serafini","year":"2012","journal-title":"J. Immunology (Baltimore Md.1950)"},{"key":"10.1016\/j.intimp.2024.111931_b0120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.111931_b0125","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/CCM.0b013e31819fcf68","article-title":"Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock","volume":"37","author":"Mikkelsen","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2024.111931_b0130","article-title":"Phlorizin ameliorates myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2024.111931_b0135","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1038\/ncomms13280","article-title":"PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation","volume":"7","author":"Xie","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2024.111931_b0140","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1016\/j.bmcl.2017.07.079","article-title":"Recent advances in JAK3 inhibition: isoform selectivity by covalent cysteine targeting","volume":"27","author":"Forster","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2024.111931_b0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10.1016\/j.intimp.2024.111931_b0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/13543776.2022.2023129","article-title":"JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016-present)","volume":"32","author":"Chen","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.intimp.2024.111931_b0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193572","article-title":"Activation of the IL-1\u03b2\/KLF2\/HSPH1 pathway promotes STAT3 phosphorylation in alveolar macrophages during LPS-induced acute lung injury","volume":"40","author":"Liang","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.intimp.2024.111931_b0160","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s10787-023-01199-9","article-title":"Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury","volume":"31","author":"Liu","year":"2023","journal-title":"Inflammopharmacology"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924004491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:01:03Z","timestamp":1719979263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924004491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"alternative-id":["S1567576924004491"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111931","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peficitinib alleviated acute lung injury by blocking glycolysis through JAK3\/STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111931"}}